What question did this study set out to answer?

The aim is to address the need for improved accessibility to immunoscintigraphy with Tc-besilesomab.

February 10, 20260 citations

Balancing innovation and accessibility in infection imaging: lessons from the 99mTcTc-besilesomab paradox.

OMO. MesnilgranteNormandie Université TLTyphanie LadrièreNormandie Université NANoémie AlloucheNormandie Université

Key Points

The aim is to address the need for improved accessibility to immunoscintigraphy with Tc-besilesomab.
Discussing the development of quantitative point-of-care HAMA assays.
Advocating for humanised or nanobody-based tracers.
Proposing harmonised European guidelines for infection imaging.
Emphasized the importance of balancing patient safety with diagnostic availability.
Highlighted that regulatory changes may lead to unintended consequences.

Abstract

This debate argues that restoring accessibility to 99mTcTc-besilesomab immunoscintigraphy requires both technological and regulatory innovation. Developing quantitative point-of-care HAMA assays, promoting humanised or nanobody-based tracers, and establishing harmonised European guidelines could help balance patient safety with diagnostic availability. The 99mTcTc-besilesomab case exemplifies how well-intentioned regulatory transitions may have unintended consequences, underscoring the need for a pragmatic equilibrium between innovation, safety, and accessibility in infection imaging.

问 AI

Bookmark

View Full Paper